Cargando…

Divergent EGFR/MAPK-Mediated Immune Responses to Clinical Candida Pathogens in Vulvovaginal Candidiasis

Vulvovaginal candidiasis (VVC) is characterized by symptomatic inflammatory responses in the vagina caused by Candida albicans and non-albicans Candida (NAC) species. The epidermal growth factor receptor (EGFR) -mitogen-activated protein kinase (MAPK) signaling pathway has been linked to immune resp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jingyun, Peng, Jingwen, Li, Dongmei, Mei, Huan, Yu, Yu, Li, Xiaofang, She, Xiaodong, Liu, Weida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204526/ https://www.ncbi.nlm.nih.gov/pubmed/35720274 http://dx.doi.org/10.3389/fimmu.2022.894069

Ejemplares similares

S7.2d Divergent EGFR/MAPK-mediated immune responses to clinical Candida pathogens in vulvovaginal candidiasis
por: Zhang, Jingyun, et al.
Publicado: (2022)

Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis
por: Ge, Gai, et al.
Publicado: (2022)

Pathogenesis and Clinical Relevance of Candida Biofilms in Vulvovaginal Candidiasis
por: Rodríguez-Cerdeira, Carmen, et al.
Publicado: (2020)

Identification of Candida Species Associated with Vulvovaginal Candidiasis by Multiplex PCR
por: Mahmoudi Rad, Mahnaz, et al.
Publicado: (2012)

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
por: Bitew, Adane, et al.
Publicado: (2018)

Candida duobushaemulonii: an emerging rare pathogenic yeast isolated from recurrent vulvovaginal candidiasis in Brazil
por: Boatto, Humberto Fabio, et al.
Publicado: (2016)

Multilocus sequence typing analysis of Candida africana from vulvovaginal candidiasis
por: Zhu, Y. X., et al.
Publicado: (2019)

Molecular association of Candida albicans and vulvovaginal candidiasis: focusing on a solution
por: David, Helma, et al.
Publicado: (2023)

A variant ECE1 allele contributes to reduced pathogenicity of Candida albicans during vulvovaginal candidiasis
por: Liu, Junyan, et al.
Publicado: (2021)

Antifungal activity of essential oils against itraconazole-resistant pathogenic Candida isolated from vulvovaginal candidiasis
por: S. AL-Janabi, Ali Abdul Hussein
Publicado: (2022)

Candidiasis vulvovaginal: revisión bibliográfica.
por: Caballero Salmeron, María Esther
Publicado: (1995)

New Treatments for Vulvovaginal Candidiasis
por: Faro, Sebastian
Publicado: (1996)

Changing Trends of Vulvovaginal Candidiasis
por: Vijaya, Doddaiah, et al.
Publicado: (2014)

Clinicomycological study of vulvovaginal candidiasis
por: Seeniammal, S., et al.
Publicado: (2021)

Isolation of Different Species of Candida in Patients With Vulvovaginal Candidiasis From Sari, Iran
por: Hedayati, Mohammad Taghi, et al.
Publicado: (2015)

Recurrent Vulvovaginal Candidiasis: a Dynamic Interkingdom Biofilm Disease of Candida and Lactobacillus
por: McKloud, Emily, et al.
Publicado: (2021)

Analysis of molecular resistance to azole and echinocandin in Candida species in patients with vulvovaginal candidiasis
por: Lotfali, Ensieh, et al.
Publicado: (2022)

Genotyping and Drug Resistance Profile of Clinical Isolates of Candida albicans from Vulvovaginal Candidiasis in the Eastern China
por: Hong, Nan, et al.
Publicado: (2022)

Virulence Factors of Candida spp. and Host Immune Response Important in the Pathogenesis of Vulvovaginal Candidiasis
por: Czechowicz, Paulina, et al.
Publicado: (2022)

An Exaggerated Monocyte-Derived Cytokine Response to Candida Hyphae in Patients With Recurrent Vulvovaginal Candidiasis
por: Rosati, Diletta, et al.
Publicado: (2020)

Glycogen Metabolism in Candida albicans Impacts Fitness and Virulence during Vulvovaginal and Invasive Candidiasis
por: Miao, Jian, et al.
Publicado: (2023)

Recurrent Vulvovaginal Candidiasis: An Immunological Perspective
por: Rosati, Diletta, et al.
Publicado: (2020)

Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp
por: Grant, Leah M., et al.
Publicado: (2022)

Clinical and morphopathological assay in vulvovaginal candidiasis
por: Manolea, Maria Magdalena, et al.
Publicado: (2022)

Insights and advances in recurrent vulvovaginal candidiasis
por: San Juan Galán, Javier, et al.
Publicado: (2023)

Candida causes recurrent vulvovaginal candidiasis by forming morphologically disparate biofilms on the human vaginal epithelium
por: Pan, Yihong, et al.
Publicado: (2023)

Mitochondrial Complex I Core Protein Regulates cAMP Signaling via Phosphodiesterase Pde2 and NAD Homeostasis in Candida albicans
por: She, Xiaodong, et al.
Publicado: (2020)

Candida albicans Multilocus Sequence Typing Clade I Contributes to the Clinical Phenotype of Vulvovaginal Candidiasis Patients
por: Zhu, Yuxia, et al.
Publicado: (2022)

Antibiofilm Activity of Essential Fatty Acids Against Candida albicans from Vulvovaginal Candidiasis and Bloodstream Infections
por: Wang, Shuai, et al.
Publicado: (2022)

Recurrent Vulvovaginal Candidiasis: Could It Be Related to Cell-Mediated Immunity Defect in Response to Candida Antigen?
por: Talaei, Zahra, et al.
Publicado: (2017)

IL-9 Integrates the Host-Candida Cross-Talk in Vulvovaginal Candidiasis to Balance Inflammation and Tolerance
por: Renga, Giorgia, et al.
Publicado: (2018)

Low prevalence of antifungal resistant Candida africana, in the C. albicans complex causing vulvovaginal candidiasis
por: Farahyar, Shirin, et al.
Publicado: (2020)

Mycobiome Study Reveals Different Pathogens of Vulvovaginal Candidiasis Shape Characteristic Vaginal Bacteriome
por: Zhao, Changying, et al.
Publicado: (2023)

Candidiasis vulvovaginal tratamiento oral con itraconazol/
por: Rodriguez Serrano, Tiburcio Manuel
Publicado: (1993)

Lamisil versus clotrimazole in the treatment of vulvovaginal candidiasis
por: Mahmoudabadi, Ali Zarei, et al.
Publicado: (2013)

Sexual function, depression, anxiety, and vulvovaginal candidiasis
por: Başer, Emre, et al.
Publicado: (2021)

Molecular Identification and Antifungal Susceptibility Pattern of Non-albicans Candida Species Isolated from Vulvovaginal Candidiasis
por: Nejat, Ziba Abbasi, et al.
Publicado: (2018)

Species distribution and susceptibility profiles of Candida species isolated from vulvovaginal candidiasis, emergence of C. lusitaniae
por: Hashemi, Seyed Ebrahim, et al.
Publicado: (2019)

The Antimicrobial Activity of Omiganan Alone and In Combination against Candida Isolated from Vulvovaginal Candidiasis and Bloodstream Infections
por: Żyrek, Dawid, et al.
Publicado: (2021)

Characterization of Candida species isolated from vulvovaginal candidiasis by MALDI-TOF with in vitro antifungal susceptibility profiles
por: Aslani, Narges, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0mcnv89v4lojujtov4fgnf3opk